Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms. Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living. In 2018, the global Novel Drug Delivery Systems in Cancer Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Novel Drug Delivery Systems in Cancer Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Novel Drug Delivery Systems in Cancer Therapy development in United States, Europe and China. The key players covered in this study Teva Johnson & Johnson Roche Takeda AbbVie Samyang Biopharmaceuticals Celgene Spectrum Pharmaceuticals, Inc. Gilead Sciences Shire (Baxalta) Merrimack Market segment by Type, the product can be split into Nanoparticles Liquid Embolics Embolization Particles Market segment by Application, split into Hospitals & Clinic Cancer Treatment Centers Others Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Novel Drug Delivery Systems in Cancer Therapy status, future forecast, growth opportunity, key market and key players. To present the Novel Drug Delivery Systems in Cancer Therapy development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions. In this study, the years considered to estimate the market size of Novel Drug Delivery Systems in Cancer Therapy are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025 For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Novel Drug Delivery Systems in Cancer Therapy Market Size Growth Rate by Type (2014-2025) 1.4.2 Nanoparticles 1.4.3 Liquid Embolics 1.4.4 Embolization Particles 1.5 Market by Application 1.5
